Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

KeyBanc maintains Sector Weight on Teladoc stock, cites ad spend view

EditorEmilio Ghigini
Published 03/13/2024, 09:46 PM
Updated 03/13/2024, 09:46 PM
© Reuters.

On Wednesday, KeyBanc Capital Markets maintained its Sector Weight rating on Teladoc Health Inc. (NYSE:TDOC), a telehealth company. The firm's analysis highlighted the company's advertising expenditures, particularly for its Direct-to-Consumer (D2C) teletherapy service, BetterHelp.

The service saw a significant increase in podcast advertising spend in January, totaling approximately $9.1 million. This represents a sequential increase of around 13.8% and a year-over-year increase of nearly 3.9%.

The commentary from KeyBanc underscored Teladoc's increased marketing investments as a strategy to boost user growth for BetterHelp. Despite this uptick in advertising spend, it was noted that the company had previously moderated its marketing expenses in an effort to prioritize profitability, especially in the fourth quarter.

The analyst from KeyBanc projects that Teladoc is likely to continue ramping up its advertising efforts in the first quarter, attributing this trend to the seasonal nature of marketing designed to drive user volumes at the beginning of the year.

The report from KeyBanc comes at a time when Teladoc has been focusing on balancing user growth with profitability. The company's decision to regulate advertising spending in the latter months aligns with a broader strategy to improve profitability metrics.

However, the expected increase in marketing expenditures in the first quarter indicates that Teladoc is still actively seeking to expand its user base, which could have implications for its financial performance.

Teladoc's approach to growing its BetterHelp platform through targeted podcast advertising spend is reflective of the company's commitment to capturing a larger share of the teletherapy market. The firm's decision to maintain its Sector Weight rating suggests that while Teladoc is making notable moves in its marketing strategy, it has yet to prompt a change in the firm's outlook on the stock.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Investors and market watchers will be looking to see how Teladoc's strategic advertising investments impact the company's user growth and financial metrics in the forthcoming quarters. The ongoing management of marketing costs against the backdrop of striving for profitability will likely continue to be a key area of focus for Teladoc and its stakeholders.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.